Sinovac Biotech Ltd
NASDAQ:SVA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Sinovac Biotech Ltd
NASDAQ:SVA
|
CN |
|
Autoneum Holding AG
SIX:AUTN
|
CH |
|
UiPath Inc
NYSE:PATH
|
US |
|
Ressources Minieres Radisson Inc
XTSX:RDS
|
CA |
|
M
|
Melisron Ltd
TASE:MLSR
|
IL |
|
M
|
Metair Investments Ltd
JSE:MTA
|
ZA |
|
Rieter Holding AG
SIX:RIEN
|
CH |
|
E
|
Emerson Electric Co
XMUN:EMR
|
US |
|
Belo Sun Mining Corp
TSX:BSX
|
CA |
|
Lectra SA
PAR:LSS
|
FR |
|
E
|
Energy Fuels Inc
F:VO51
|
US |
|
K
|
Kirin Holdings Co Ltd
DUS:KIR
|
JP |
Intrinsic Value
Is SVA undervalued or overvalued?
See the intrinsic value estimate for Sinovac Biotech Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
SVA looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with SVA’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Sinovac Biotech Does
Sinovac Biotech is a vaccine company that develops, makes, and sells vaccines for infectious diseases. Its products are used in public vaccination programs and by hospitals, clinics, and distributors that supply immunization needs. The company’s portfolio includes vaccines for diseases such as hepatitis, influenza, varicella, hand-foot-and-mouth disease, and COVID-19.
- Headquarters
- China CN
- Employees
- 3 037
- IPO date
- Nov 13, 2009
Earnings Waterfall
Sinovac Biotech Ltd
The intrinsic value for Sinovac Biotech Ltd (SVA) under the Base Case is hidden USD.
Compared with the current market price of 6.47 USD, the stock appears hidden.